Company Profiles

driven by the PitchBook Platform

Alkeus Pharmaceuticals

Description

Developer of treatments for blindness. The company develops a new oral investigational medicine, ALK-001, that treats Stargardt disease.

2010

Founded

PRIVATE

Status

Grant

Latest Deal Type

$165k

Latest Deal Amount

$100k

Total Amount Raised

1

Investors

Description

Developer of treatments for blindness. The company develops a new oral investigational medicine, ALK-001, that treats Stargardt disease.

Website:

www.alkeus.com

Ownership Status

Privately Held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Drug Discovery

Other Industries

Other Healthcare Services

Primary Office

Boston, MA United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Alkeus Pharmaceuticals's full profile, request a free trial.

    Alkeus Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Alkeus Pharmaceuticals Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    MassChallengeAccelerator/IncubatorMinority000 0000000 0000
    MassChallenge Accelerator/Incubator

    Alkeus Pharmaceuticals Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Leonide Saad Ph.DChief Executive Officer, President & Co-Founder
    Ilyas Washington Ph.DScientific Co-Founder
    Joshua Boger Ph.DChairman
    Leonide Saad Ph.D Chief Executive Officer, President & Co-Founder
    Ilyas Washington Ph.D Scientific Co-Founder
    Joshua Boger Ph.D Chairman

    Alkeus Pharmaceuticals Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Joshua Boger Ph.DSelfChairman000 0000
    Joshua Boger Ph.D Chairman Self
    Request full access to PitchBook